News for DGX Stock

Quest Diagnostics Introduces Testing for Oropouche Virus Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease Quest Diagnostics Releases 2024 Corporate Responsibility Report Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025 Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference Quest Diagnostics Declares Quarterly Cash Dividend Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025 Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025 Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics Quest Diagnostics to Host Investor Day on March 19, 2025 GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer Everyday Hero - Kris Constantino Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025 Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management Quest Diagnostics Advances Environmental Stewardship With Renewable Energy Initiatives, Waste Reduction, and ISO 14001 Certifications in 2023 Quest Diagnostics Fortifies Patient Data Privacy and Cybersecurity With Robust Safeguards and Ongoing Threat Mitigation Strategies Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health Parker Family Health Center Celebrates Expansion Quest Diagnostics Declares Quarterly Cash Dividend My Quest Story - Malissa Mueller Nonprofit Partners With Newark Black Churches To Bridge Health Disparities Career Progression - Jessie Hutchens Maxwell My Quest Story – Martha Baer Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024 My Quest Story - Adam Slough Quest Diagnostics’ Q4HE Initiative Advances Health Equity in Underserved Communities With Strategic Coalition Building and Targeted Funding in 2023 Quest Diagnostics Introduces Specimen Self-Collection for Common Genital Tract Infection Testing at Nationwide Network of Patient Service Centers Quest Diagnostics Completes Acquisition of Lab Assets from OhioHealth My Quest Story - Branda Burke Growing Something Greater in Secaucus, NJ Quest Diagnostics Expands Access and Affordability of Diagnostic Services in 2023 With Enhanced Financial Assistance and Innovative Testing Solutions Quest Diagnostics Enhances Patient-Centered Care With Streamlined Services, Innovative Testing, and a Commitment to Health Equity in 2023 Summer Intern Spotlight: Hear What Our Interns Learned! Quest Diagnostics Amplifies Community Impact With Enhanced Corporate Giving Program and Record Employee Volunteerism in 2023 Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024 Quest Diagnostics Elevates Employee Well-Being With Relaunched HealthyQuest Program, Holistic Support Initiatives, and High Engagement in 2023 Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast Quest Diagnostics Completes Acquisition of Select Lab Assets from Allina Health Quest Diagnostics Empowers Employees With Enhanced Education Assistance and Career Growth Programs, Achieving Record Engagement in 2023 Quest Diagnostics to Speak at the Morgan Stanley 22nd Annual Global Healthcare Conference Quest Career Progression: Blair Rule 100 New Moms Celebrated at Community Baby Shower Hosted by Q4HE Grantee Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation My Quest Story - Pat Beall Quest Diagnostics to Acquire University Hospitals' Outreach Laboratory Services Business 2023 Quest Diagnostics Corporate Responsibility Report: CEO Jim Davis Highlights 'Care at Our Core' and Commitment to a Healthier World Quest Diagnostics Prices $1.85 Billion of Senior Notes questhealth.com Introduces 13 New Blood Tests to Identify Micronutrient Deficiencies Quest Diagnostics Declares Quarterly Cash Dividend Pregnant Women Undertested for STIs, Finds Quest Diagnostics Health Trends® Study of Over 4 Million Pregnancies My Quest Story - Jamie Croft Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year My Quest Story - Carol Ann Mandichak 40 Graduate From Bread of Life Academy, Highlighting Impact Toward Health Equity Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 Leveraging the Power of Collective Impact To Increase Access to Maternal and Infant Healthcare and Education Quest Diagnostics to Acquire Outreach Laboratory Services of OhioHealth Quest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for Canadians Quest Diagnostics Releases 2023 Corporate Responsibility Report Quest Diagnostics to Acquire Select Lab Assets from Allina Health Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024 My Quest Story - Mark Hamilton Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics' Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors Lab Week 2024 - Lisa Szeto-Tay Quest Diagnostics Grows Interest in Sustainability With Healthy NewsWorks Students Blood-based MRD Test for Cancer Recurrence Can Generate Cost Savings in Colorectal Cancer Treatment, Finds Study in JAMA Health Forum Lab Week 2024 - Mimi Perdue-Loan Ruth Clements Speaks at National Action Network Event Addressing Health Inequities Lab Week 2024 - Deepika Kumar Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors Quest Diagnostics Declares Quarterly Cash Dividend Workforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug Tests Lab Week 2024 - Javarus Smith Helping To Change Perceptions of Bloodwork by Being ‘Phenomenal’ Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With PathAI Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer Quest Supports Expansion of Community Center and Provides No-Cost Wellness Testing to Newark Faith Community Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease Q4HE Initiative Recognized for Efforts To Reduce Health Disparities My Quest Story - Jessica Clow Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay My Quest Story - Pauline Chaves She Is Not Skipping a Beat, and Patients Are Noticing Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease My Quest Story - Eddy Hurst Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024 Quest Colleague Is Exhibiting Care for Every Patient in Her Chair Phlebotomist's Actions Keep One Patient Coming Back My Quest Story - Allan Mendez First PFAS "Forever Chemicals" Consumer-Initiated Blood Test With Physician Consult Launches on questhealth.com On Rare Disease Day, Q4HE Collaboration Highlights Purpose in Action Ten Years Running: FORTUNE Names Quest Diagnostics One of 2024 "World's Most Admired Companies" Living Our Purpose - Ivelisse Lugo Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference Quest Diagnostics and Instacart Collaborate to Reduce Food Insecurity Across the United States with Integrated Patient Health Coaching and Nutritious Grocery Delivery Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection Quest Diagnostics Debuts MelaNodal Predict™ Test, Personalizing Melanoma Risk Prediction to Help Patients Forgo Invasive Surgery First PFAS "Forever Chemicals" Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.com Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share Ten Years Running: FORTUNE Names Quest Diagnostics one of 2024 "World's Most Admired Companies" Fitbit and Quest Diagnostics Collaborate To Advance Research on the Use of Wearable Devices To Improve Metabolic Health Haystack Oncology, developer of Haystack MRD™, and TriSalus Life Sciences collaborate in connection with the clinical development of TriSalus' TLR9 agonist in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and pancreatic adenocarcinoma Quest Diagnostics to Release Fourth Quarter and Full Year 2023 Financial Results on February 1, 2024 Fitbit and Quest Diagnostics Collaborate to Advance Research on the Use of Wearable Devices to Improve Metabolic Health Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing Quest Diagnostics Acquires Select Assets of Outreach Lab Services Business of Steward Health Care System Haystack Oncology and Alliance Foundation Trials collaborate to use Haystack MRD™ technology in phase II clinical trial for unresectable stage III NSCLC No-Cost Testing Helps Bolster I-HEAL Community Wellness Day in Mississippi Delta Region Quest Diagnostics to Speak at the 42nd Annual J.P. Morgan Healthcare Conference Quest Diagnostics Names Yuri A. Fesko, M.D., Senior Vice President and Chief Medical Officer Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis Quest Diagnostics Launches New 88-Compound Novel Psychoactive Substance Test Panel Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation’s Corporate Equality Index for Seventh Consecutive Year Haystack Oncology and Rutgers Cancer Institute Collaborate to use Haystack MRD™ in Clinical Study of Early-Stage Triple-Negative Breast Cancer Quest Diagnostics Multi-Pronged Approach to Waste Reduction New Report From Quest Diagnostics Unveils Priorities for Community Health Centers Universal DX Announces Strategic Collaboration With Quest Diagnostics To Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States Quest Diagnostics and CDC Expand Public Health Research Collaboration to Better Understand Hepatitis C Burden in the United States Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index for Seventh Consecutive Year ISO Standardization & Climate Action at Quest Diagnostics Quest Volunteers Bring Treats, No Tricks, to Ronald McDonald House New York Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis Community Engagement at Quest Diagnostics Quest Diagnostics Approach to Patient- and Consumer-Centered Care Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States Supply Chain Management at Quest Diagnostics Quest Diagnostics Declares Quarterly Cash Dividend Our Work Is Helping Quest Land on Some Noteworthy Lists Corporate Responsibility, Governance, and Ethics at Quest Diagnostics Quest Diagnostics Launches Mobile Phlebotomy Service, Enabling Convenient At-Home Specimen Collection in the United States Quest Diagnostics Recognized for Commitment to Closing Boardroom Gender Gap Quest for Health Equity 2023 Summer Intern Spotlights Developing and Retaining Talent at Quest Diagnostics Quest Diagnostics Prices $750 Million of Senior Notes Diadem SpA Announces Exclusive U.S. Licensing Agreement with Quest Diagnostics for Its AlzoSure® Predict Alzheimer's Disease Prognostic Technology Creating a Positive Employee Experience Based on the Quest Way Quest Diagnostics Reports Third Quarter 2023 Financial Results; Updates Guidance for Full Year 2023 Think Pink: Quest Supports Women’s Breast & Heart Initiative’s National Pink Day Wellness Event Expanding Healthcare Access and Affordability at Quest Diagnostics Neway Forms Lab Services Agreement with Quest Diagnostics to Speed Quality ESRD Testing Quest Diagnostics to Release Third Quarter 2023 Financial Results on October 24, 2023 Working Together To Create a Healthier World, One Life at a Time Americares and Quest Diagnostics Expand Collaboration to Support Health Equity Quest Diagnostics to Speak at the Baird 2023 Global Healthcare Conference Quest Diagnostics Granted FDA Breakthrough Designation for its Adeno-associated virus (AAV) Test Quest Diagnostics Releases 2022 Corporate Responsibility Report Rutgers University and Quest Diagnostics Double H.O.P.E. Clinic Capacity With Expanded Collaboration Making Connections To Care: Quest Supports Inspiring Health Equity Event Hosted by Sisters on the Vineyard Quest Diagnostics Declares Quarterly Cash Dividend Inflammation Marker Signifies Increased Mortality Risk, Finds New Study in PLOS ONE Quest Introduces First-To-Market Consumer-Initiated Blood Test for Alzheimer's Disease Risk Assessment on questhealth.com Quest Diagnostics Reports Second Quarter 2023 Financial Results; Updates Guidance for Full Year 2023 Q4HE Collaborates With Western University of Health Sciences To Support Biopsies Save Lives Quest Diagnostics Named a 'Best Place To Work for Disability Inclusion' for Sixth Consecutive Year Quest Diagnostics Employees Support Healthy NewsWorks Student Journalists Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading Quest Diagnostics Named a 'Best Place to Work for Disability Inclusion' for Sixth Consecutive Year Quest Launches Consumer-Initiated Genetic Test on questhealth.com to Deliver Personalized, Actionable Health Risk Insights Analysis of Half a Billion Lipid Tests from Five Continents Reveals Wide Variation of Lipid-Associated Risk of Heart Disease by Country and Sex Quest and Proov Collaborate to Bring Novel Home Fertility Test to Women Through questhealth.com Inclusion in Action: Clifton and West Hills Labs Quest Diagnostics to Release Second Quarter 2023 Financial Results on July 26, 2023 Quest Diagnostics Completes Acquisition of Haystack Oncology, Adding Sensitive MRD Liquid Biopsy Technology to Cancer Diagnostics Portfolio New Tests Yield Actionable Insights Q4HE Teams Up With Experience Camps To Help Children Work Through Grief Environmental Sustainability Drives Operational Excellence Quest Diagnostics Elects Luis A. Diaz, Jr., M.D. to Its Board, Expanding the Number of Directors to 10 Integrity: A Fundamental Value Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference Wherever We Are, Quest Is Part of the Community Quest Diagnostics to Speak at the William Blair 43rd Annual Growth Stock Conference Quest’s Chicagoland Laboratory Hosts Americares Leaders During Lab Week Post-Accident Workforce Drug Positivity for Marijuana Reached 25-Year High in 2022, Quest Diagnostics Drug Testing Index Analysis Finds Quest Diagnostics Elects Luis A. Diaz, Jr., M.D. to its Board, Expanding the Number of Directors to 10 Q4HE Grantee, American Heart Association, Celebrates Hispanic and Black Scholars Quest Diagnostics Declares Quarterly Cash Dividend Bringing Our Whole Selves To Work Quest’s State-of-the-Art Laboratory in Clifton, NJ Hosts American Heart Association’s Hispanic Serving Institutions Scholars Program Quest HealthConnect(TM): Personalized Access to Quality Healthcare Quest Diagnostics Extends Alzheimer's Disease Portfolio with New AI-Powered Test Service from uMETHOD Health Quest for Health Equity Teams Up With Health Coalition of Passaic County for Black Women's Maternal Health Week Quest Diagnostics Reports First Quarter 2023 Financial Results; Updates Guidance for Full Year 2023 Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio Safely Working Together Quest Diagnostics and NewYork-Presbyterian Complete Laboratory Services Acquisition Our Culture Rests on Equity in Compensation and Opportunity Quest Diagnostics' Purpose Quest Diagnostics Unveils Advanced Transplant Diagnostic Services Featuring Anywhere-Access in the United States Quest Diagnostics to Release First Quarter 2023 Financial Results on April 27, 2023 Q4HE Aims To Improve Healthcare Access The Los Angeles County Department of Public Health Joins Forces With Quest for Health Equity To Supply Blood Lead Testing at No Charge in the Exide Area Sesame Workshop Launches New Resources for Parents, Caregivers, and Healthcare Providers Addressing Health and Well-Being Inequities, With Support From Quest Diagnostics Quest Diagnostics Unveils Advanced Transplant Diagnostic Services Featuring Anywhere-Access in the United States First-of-Its-Kind Post-COVID-19 Panels Available at questhealth.com Quest Diagnostics Completes Acquisition of Northern Light Laboratory in Maine Quest Diagnostics to Discuss Strategic Priorities to Drive Growth and Create Shareholder Value at 2023 Investor Day Educating Early Learners To Create Better Health Outcomes Keeping Kids and Families Healthy and Active Biopsy Devices Market Predicted to Achieve Striking Growth of USD 3.96 Billion with Healthy CAGR of 7.3% by 2029, Size, Share, Trends, Demand and Competitive Analysis Quest Diagnostics Board of Directors Elects James E. Davis Chairman of the Board Quest Provides No-Cost Laboratory Testing to Underserved Communities in Dallas Bringing Healthcare to Children in Rural Communities Bringing COVID-19 Testing to New York's First Responders Reducing COVID-19's Impact in Long-Term Care Facilities Quest Diagnostics Teams Up with Tower Health to Deliver High-Value, Innovative Laboratory Services Mobile Van Provides Health Immunizations and More for Chicago Children Quest Diagnostics and NewYork-Presbyterian Agree to Laboratory Services Transaction Quest Diagnostics to Host Investor Day on March 16, 2023 Cleveland Diagnostics Announces Agreement with Quest Diagnostics to Expand Patient Access to IsoPSA® Prostate Cancer Testing Transitioning to Life With COVID-19: A New Normal QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2023 Quest Diagnostics Increases Dividend 7.6% To $0.71 Per Quarter; Announces $1 Billion Increase in Share Repurchase Authorization FORTUNE Magazine Names Quest Diagnostics one of 2023 "World's Most Admired Companies" for Ninth Consecutive Year Helping Puerto Ricans Recover From Long COVID Advancing Healthcare Equity in Underserved Communities More Americans Know Their Horoscope Sign Than Their Blood Type, Survey Reveals Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test Quest Diagnostics to Release Fourth Quarter and Full Year 2022 Financial Results on February 2, 2023 Making Health Equity a Priority for the Most Vulnerable Among Us: A Message From Quest for Health Equity's Ruth Clements Pack Health to Expand in Birmingham to Accelerate Growth of Health Coaching Services Nationwide Quest for Health Equity Teams Up With the American Heart Association To Help Indigenous People Through Community-Based Health Centers Watch: ConferMED Brings More Equitable Access to Specialty Care with Grant from Quest Diagnostics Foundation Quest Diagnostics' Initiatives for Returning to the “Business of Play” Nationwide COVID-19 Testing Initiatives To Support Safer Classrooms Quest Provides No-Cost Testing During Community Wellness Day in Mississippi Delta Region Quest Diagnostics to Speak at the 41st Annual J.P. Morgan Healthcare Conference One in Two Patients Tested Misuse Prescription Drugs, Finds 10th Annual Quest Diagnostics Health Trends® Report Quest Diagnostics and Northern Light Health Form Strategic Laboratory Collaboration to Improve Access to Affordable Diagnostic Services in Maine Sonora Quest Streamlines Access to At-Home Lab Services Through Getlabs Collaboration Quest Diagnostics Awarded Laboratory Stewardship Platform and Services Agreement with Premier, Inc. Quest Diagnostics Completes Acquisition of Outreach Lab Services Business of Summa Health ConferMED, through Grant from the Quest Diagnostics Foundation, now Providing Specialty eConsults to Front Line Primary Care Providers at Federally Qualified Health Centers in Five Key Metropolitan Areas DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test Quest Diagnostics Declares Quarterly Cash Dividend Quest Introduces First of Its Kind Fitness Tests Built By and For Athletes on questhealth.com Quest Diagnostics Named in Fast Company's Second Annual List of "Brands That Matter" Quest Diagnostics Completes Leadership Succession as Jim Davis Becomes CEO and President, Joins Board of Directors SAINT LOUIS UNIVERSITY TEAMS UP WITH QUEST DIAGNOSTICS ON ACCELERATED BACHELOR OF SCIENCE IN MEDICAL LABORATORY SCIENCE Bread of Life, Inc. teams up with the Quest Diagnostics Foundation and local community partners to improve access to healthcare and create job opportunities for underserved communities Sesame Workshop and Quest Diagnostics Team Up to Address Health and Well-Being Inequities with Resources Connecting Parents and Healthcare Providers Quest Diagnostics Reports Third Quarter 2022 Financial Results; Raises Guidance for Full Year 2022 Decode Health Collaborates with Quest Diagnostics to Speed Biomarker Discovery for Drug and Diagnostics Development Quest Encourages Consumers to "Put Your ____ To The Test" in Bold and Disruptive New Ad Campaign Quest Diagnostics Announces Organizational Changes to Accelerate Growth and Drive Operational Excellence Breast and Prostate Cancer Diagnoses Still Lagging During Second Full Year of COVID-19 Pandemic, Quest Diagnostics Health Trends® Study Finds Quest Diagnostics to Acquire Outreach Lab Services Business of Summa Health Quest Diagnostics to Release Third Quarter 2022 Financial Results on October 20, 2022 Quest Diagnostics Teams Up With Lee Health to Deliver High-Value, Innovative Laboratory Services Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Technology Awards Takeda Launches CDPATH™, a Personalized Prognostic Tool, Advancing Innovation for Patients with Crohn's Disease Quest Diagnostics to Speak at the Morgan Stanley 20th Annual Global Healthcare Conference FDA Authorizes Quest Diagnostics' Proprietary Monkeypox Test for Emergency Use uMETHOD Taps Getlabs to Deliver In-Home Diagnostics for Patients with Cognitive Decline Quest Diagnostics Aims to Close Gaps in Maternal Healthcare with New Obstetrics Test Panel that Includes Hepatitis C Screening Paige Announces Partnership with Sonora Quest Laboratories to Accelerate Precision Diagnostics for Patients Across Arizona Quest Diagnostics Declares Quarterly Cash Dividend QUEST DIAGNOSTICS BRIDGING ACCESS TO BETTER HEALTH FOR HISPANICS THROUGH ES TU PODER INITIATIVE Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Fifth Consecutive Year High Rates of Chronic Hepatitis B and Tuberculosis Co-Infection Observed in Nationally Representative Quest Diagnostics Study Quest Diagnostics Reports Second Quarter 2022 Financial Results; Raises Guidance for Full Year 2022 Rite Aid and Quest Diagnostics Expand Access to COVID-19 PCR Testing Nationwide Quest Diagnostics Launches Monkeypox Virus Testing Quest Diagnostics Releases 2021 Corporate Responsibility Report Quest Diagnostics Partners with CDC to Extend $0 Out-of-pocket COVID-19 Diagnostic Testing to Underserved Communities Quest Diagnostics to Release Second Quarter 2022 Financial Results on July 21, 2022 Pack Health Named Best Wellness Platform at Future Digital Awards by Juniper Research New Quest Diagnostics Health Trends® Study, in Collaboration with CDC, Shows Less Than Half of Pregnant People Screened for Hepatitis C Quest Diagnostics Names Sam Samad Executive Vice President and Chief Financial Officer Quest Diagnostics Presents Late Breaker Study Demonstrating Diabetes Prescription Cost Reductions Achieved for Participants in an Employer-Sponsored Health Program at the 82nd American Diabetes Association Scientific Sessions Quest Diagnostics to Speak at the Jefferies Healthcare Conference Quest Diagnostics CHRO Receives "CHRO Lifetime Achievement Award" Quest Diagnostics Declares Quarterly Cash Dividend Quest Diagnostics to Speak at the UBS 2022 Global Healthcare Conference Survey of Human Resource Executives and Office Workers Suggests Employee Health May be a Key Ingredient to Addressing the "Great Resignation" Physicians Foresee an Alzheimer's Disease Treatment Revolution Supported by Advanced Testing Tools, New Quest Diagnostics Report Finds Quest Diagnostics Reports First Quarter 2022 Financial Results; Raises Guidance for Full Year 2022 Quest Diagnostics Announces Organizational Changes to Accelerate Growth and Drive Operational Excellence Quest Diagnostics Adds Diabetic Retinopathy Screening Through its Patient Service Centers in Collaboration with IRIS Quest Diagnostics to Release First Quarter 2022 Financial Results on April 21, 2022 Workforce Drug Test Positivity Climbs to Highest Level in Two Decades, Finds Quest Diagnostics Drug Testing Index Analysis Quest Diagnostics Granted CDC Contract to Support COVID-19 Infection and Vaccination Seroprevalence Research Quest Diagnostics Foundation to support Humanitarian Efforts in Ukraine with $500,000 gift to Project HOPE Quest Diagnostics Announces Leadership Succession Plan QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2022; INCREASES QUARTERLY DIVIDEND 6.5% TO $0.66 PER SHARE FORTUNE Magazine Names Quest Diagnostics one of 2022 "World's Most Admired Companies" for Eighth Consecutive Year Walmart and Quest Diagnostics Empower People to Take Control of Their Healthcare Through New Consumer-Initiated Laboratory Testing Solution Powered by QuestDirect™ Through Walmart.com Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index for Sixth Consecutive Year Quest Diagnostics Launches COVID-19 Rapid Antigen Test with Observed Collection for Consumers Through QuestDirect™ Quest Diagnostics Launches Virtual Preventive Care Service Through QuestDirect™ to Help Individuals Take Control of Their Health Quest Diagnostics to Acquire Patient-Engagement Company Pack Health to Improve Value-Based Care QUEST DIAGNOSTICS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS Quest Diagnostics to Release Fourth Quarter and Full Year 2021 Financial Results on February 3, 2022 QUEST DIAGNOSTICS TO SPEAK AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Quest Diagnostics Earns Gold Status in American Heart Association's 2021 Workplace Health Achievement Index Quest Diagnostics Acquires South Carolina-based Labtech Diagnostics Quest Diagnostics Now Offers Biocept's Liquid Biopsy Test for Lung Cancer, Expanding its Menu of Advanced Cancer Diagnostics Quest Diagnostics Declares Quarterly Cash Dividend Majority of Physicians Worry Signs of Addiction Were Missed During Pandemic, Finds New Quest Diagnostics Health Trends® Report Quest Diagnostics To Speak At The Credit Suisse 30™ Annual Healthcare Conference Quest Diagnostics Reports Third Quarter 2021 Financial Results, Raises Outlook for Full Year 2021 Quest Diagnostics to Provide K-12 School COVID-19 Testing in Collaboration with Ginkgo Bioworks to Support Safer Classroom Learning in Texas for New Statewide School Testing Program Quest Diagnostics to Introduce Ki-67 IHC MIB-1 pharmDx, the First Companion Diagnostic for Eli Lilly and Company's Verzenio® (abemaciclib), a CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer Quest Diagnostics Debuts Next-Generation Lab Facility in Clifton, NJ Quest Diagnostics and the Boston Athletic Association Team Up to Provide Onsite COVID-19 Diagnostic Testing for the 125th Boston Marathon Quest Diagnostics To Release Third Quarter 2021 Financial Results On October 21 Over Half of U.S. Children Have Detectable Levels of Lead in their Blood, Finds Quest Diagnostics Health Trends® Study Published in JAMA Pediatrics Quest Diagnostics Updates Outlook For Full Year 2021 Cancer Diagnoses Declined Sharply During First Year of COVID-19 Pandemic, Finds Quest Diagnostics Health Trends® Study Published in JAMA Network Open Quest Diagnostics to Speak at the Morgan Stanley 19th Annual Global Healthcare Conference Quest Diagnostics Elects Tracey C. Doi to Board of Directors Quest Diagnostics Declares Quarterly Cash Dividend Quest Diagnostics Reports Second Quarter 2021 Financial Results; Establishes Full Year 2021 Outlook TrustAssure™ Announces Travel and Live Event Covid Testing through a Collaboration with Quest Diagnostics Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Fourth Consecutive Year Quest Diagnostics and Local Chapters of Feeding America, Big Brothers Big Sisters and Federally Qualified Health Centers Team Up to Address the Hidden Pandemic's Impact on Underserved Communities Quest Diagnostics To Release Second Quarter 2021 Financial Results On July 22 Biocept to Collaborate with Quest Diagnostics to Provide Advanced NGS-Based Liquid Biopsy Testing for Patients with Lung Cancer Quest Diagnostics Releases Annual Corporate Responsibility Report Quest Diagnostics Completes Acquisition of Mercy's Outreach Laboratory Services Business Marijuana Workforce Drug Test Positivity Continues Double-Digit Increases to Keep Overall Drug Positivity Rates at Historically High Levels, Finds Latest Quest Diagnostics Drug Testing Index™ Analysis Quest Diagnostics and Paige Form Collaboration to Advance AI-generated Pathology Insights to Improve Cancer Diagnosis and Care Social & Health Research Center and Quest Diagnostics Team Up to Address Childhood Hunger and Obesity Exacerbated by COVID-19 in Underserved Communities Quest Diagnostics Declares Quarterly Cash Dividend Quest Diagnostics To Speak At The Jefferies Virtual Healthcare Conference Quest Diagnostics Expands Eligibility for $0 Out-of-Pocket COVID-19 Testing Through QuestDirect™ To Assist in Combatting the Pandemic and Help Support Safer Travel, Events and Gatherings Nationwide New Health Trends® Study by Quest Diagnostics in Collaboration with CDC Reveals Concerning Decreases in Hepatitis C Testing and Treatment During First Months of COVID-19 Pandemic Ginkgo Bioworks Teams with Quest Diagnostics to Provide COVID-19 Testing for K-12 Schools Nationwide Quest Diagnostics To Speak At BofA Securities 2021 Virtual Healthcare Conference Quest Diagnostics Reports First Quarter 2021 Financial Results; Announces Plan for $1.5 Billion Accelerated Share Repurchase Quest Diagnostics and Blueprint Genetics to Present New Insights from Genetic Testing at the 2021 Annual American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting Quest Diagnostics To Release First Quarter 2021 Financial Results On April 22 Quest Diagnostics Sells Ownership Interest in Q² Solutions to IQVIA Zora Biosciences Licenses Ceramide Technology to Quest Diagnostics for Cardiovascular Mortality Prediction Test Quest Diagnostics Updates Strategic Growth Drivers and Provides Long-Term Outlook at 2021 Virtual Investor Day Quest Diagnostics and Mercy Broaden Access to Innovative, Convenient Lab Services in the Midwest 98point6 to Provide Text-Based Virtual Care for Quest Diagnostics Employer Health Screenings Genalyte and Sonora Quest Laboratories Partner to Provide Predictive Analytics for Cigna's Medicare Advantage Plan Quest Diagnostics Introduces New COVID-19 Semi-quantitative Serology Test Service Quest Diagnostics Announces Board Leadership Changes GRAIL and Quest Diagnostics Announce Collaboration to Support Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test Quest Diagnostics To Speak At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference EmblemHealth and Quest Diagnostics Renew Long-Standing Strategic Relationship Quest Diagnostics to Host Virtual Investor Day On March 11, 2021 Quest Diagnostics Reports Fourth Quarter And Full Year 2020 Financial Results; Establishes Outlook For First Half Of 2021 Quest Diagnostics Increases Dividend 10.7% To $0.62 Per Quarter; Announces $1 Billion Increase in Share Repurchase Authorization Quest Diagnostics Named One of 2021 "World's Most Admired Companies" by FORTUNE Magazine for Seventh Consecutive Year With COVID-19 on the Rise Amid Vaccine Shortages, Black Clergy Join National Effort to Ramp up COVID-19 Testing in Communities Hardest Hit by Coronavirus Black and Hispanic/Latinx Americans Less Confident in Ability to Access COVID-19 Vaccines, Treatments and Healthcare than White Americans, Finds Quest Diagnostics Health Trends™ Analysis Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19 Quest Diagnostics To Release Fourth Quarter And Full Year 2020 Financial Results On February 4 Hackensack Meridian Health and Quest Diagnostics Partner to Deliver High-Value, Innovative Laboratory Services Leading Black Clergy Meet with Dr. Fauci and Nation's Top Doctors in Historic Summit to Address COVID-19 in the Black Community Quest Diagnostics and The Commons Project to Deliver Convenient Access to Lab Data -- Including COVID-19 Test Results -- Through the CommonHealth App Quest Diagnostics Raises Outlook for Full Year 2020 New Quest Diagnostics Health Trends™ Survey Reveals COVID-19 Testing Hesitancy Among Americans, With 3 of 4 Avoiding a Test When They Believed They Needed One Quest Diagnostics Earns Gold Status in American Heart Association's 2020 Workplace Health Achievement Index Quest Diagnostics Teams Up with Two Health Systems to Deliver High-Value, Innovative Laboratory Services Quest Diagnostics Declares Quarterly Cash Dividend Quest Diagnostics To Speak At The Credit Suisse 29th Annual Virtual Healthcare Conference Quest Diagnostics and Catapult Health Provide Virtual Preventive Care Services for Employers During COVID-19 Pandemic and Beyond Quest Diagnostics Reports Third Quarter 2020 Financial Results, Reflecting Continued Demand for COVID-19 Testing and Rapid Recovery in Health Care Utilization National Business Group on Health Honors Quest Diagnostics with Best Employers: Excellence in Health & Well-Being Award Fentanyl and Heroin Misuse Skyrockets During COVID-19 Pandemic, Finds Quest Diagnostics Health Trends Study Quest Diagnostics Receives 2020 C. Everett Koop National Health Award for Outstanding Employee Health Program CLEAR and Quest Diagnostics Collaborate to Integrate COVID-19 Test Results with "Health Pass" for Safer Environments Quest Diagnostics To Release Third Quarter 2020 Financial Results On October 22 Quest Diagnostics Launches Three New Combined COVID-19 and Respiratory Virus Tests Quest Diagnostics Now Offers Two Consumer-Initiated and Physician-Ordered COVID-19 Diagnostic Test Options for Active COVID-19 Infection Through QuestDirect™ Quest Diagnostics To Speak At The Morgan Stanley 18th Annual Healthcare Conference Quest Diagnostics Updates Outlook For Full Year 2020 Chlamydia and Gonorrhea Positivity Surges in Women Ages 18-30 Years, Finds Quest Diagnostics Health Trends Study Quest Diagnostics To Speak At The 2020 Wells Fargo Virtual Healthcare Conference Workforce Drug Testing Positivity Climbed to Highest Rate in 16 Years, New Quest Diagnostics Drug Testing Index™ Analysis Finds Quest Diagnostics and Quest Diagnostics Foundation Launch Initiative to Reduce Health Disparities in Underserved Communities Quest Diagnostics Declares Quarterly Cash Dividend Quest Diagnostics Releases Annual Environmental, Social & Governance Report Quest Diagnostics Launches Automated Next Generation Sequencing (NGS) Engine To Power AncestryHealth® Quest Diagnostics Reports Second Quarter 2020 Financial Results Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Third Consecutive Year HPV Test Misses Twice as Many Women Who Develop Cervical Cancer as Cotesting, Quest Diagnostics Health Trends™ Study Finds CEO Roundtable on Cancer Celebrates Employers marking Ten-Year CEO Cancer Gold Standard™ Anniversary Quest Diagnostics Completes Acquisition of Mid America Clinical Laboratories, Now Provides Professional Lab Management for Nearly 30 Hospitals of Community Health Network and Ascension St. Vincent in Indiana FDA Authorizes New Quest Diagnostics Lab Method Designed to Increase COVID-19 Molecular Diagnostics Capacity FDA Authorizes Quest Diagnostics COVID-19 Diagnostic Testing for Specimen Pooling for Emergency Use Quest Diagnostics Announces Preliminary Second Quarter 2020 Financial Results Quest Diagnostics Marks 10 Years of Commitment to Reducing Employee Cancer Risk as CEO Cancer Gold Standard™ Employer Quest Diagnostics to Expand in Indiana with Acquisition of Outreach Lab Businesses of Community Health Network and Ascension St. Vincent Now Serviced Through Mid America Clinical Laboratories